Physician
Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $263K by Medicaid between Mar 2021 and Nov 2024, across 60 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 36% of everything it billed.
33Billing provider infoINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
LAKE CITY, FL 32055
LAKE CITY, FL 32055
33aNPI1467028423assigned 06/01/2021
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$263K
24GClaims106,181
24DCodes billed60
24AFirst – last monthMar 2021 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#41 of 207
Median peer was paid$39K
This provider vs. median6.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RODKEY, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 8,586 | $3K | |
| 2022 | 17,534 | $35K | |
| 2023 | 41,596 | $123K | |
| 2024incomplete | 38,465 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 36% | 4,386 | 3,989 | $95K |
| 87430 | 8.7% | 5,198 | 4,858 | $23K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.9% | 748 | 665 | $16K |
| 80053 | Comprehensive metabolic panel | 4.6% | 7,633 | 5,797 | $12K |
| 87400 | 4.4% | 3,066 | 1,810 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.2% | 909 | 867 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.9% | 5,252 | 2,687 | $8K |
| 84484 | 2.8% | 4,936 | 3,819 | $7K | |
| 85027 | 2.7% | 13,999 | 8,914 | $7K | |
| 87040 | 2.6% | 3,231 | 2,733 | $7K | |
| 83605 | 2.6% | 3,905 | 3,124 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 468 | 439 | $5K |
48 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 8,152 | $5K |
| 82803 | 1.9% | 1,474 | $5K | |
| 83880 | 1.6% | 1,122 | $4K | |
| 81025 | 1.5% | 2,222 | $4K | |
| 84703 | 1.2% | 1,354 | $3K | |
| 87070 | 1.2% | 1,708 | $3K | |
| 83735 | 1.1% | 5,706 | $3K | |
| 87420 | 1.1% | 342 | $3K | |
| 80047 | 1.0% | 1,949 | $3K | |
| 87280 | <1% | 333 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 874 | $2K |
| 83690 | <1% | 3,806 | $2K | |
| 84702 | <1% | 545 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 586 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 468 | $1K |
| 85730 | <1% | 2,419 | $1K | |
| 81003 | <1% | 3,529 | $1K | |
| 81001 | <1% | 2,872 | $1K | |
| 85610 | <1% | 3,133 | $897.96 | |
| 80076 | <1% | 3,080 | $891.45 | |
| 87186 | <1% | 336 | $601.44 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 184 | $577.48 |
| 84100 | <1% | 1,790 | $560.95 | |
| 87077 | <1% | 623 | $532.51 | |
| 80306 | <1% | 409 | $514.73 | |
| 80329 | <1% | 31 | $398.55 | |
| 80061 | Lipid panel | <1% | 158 | $387.82 |
| 82550 | <1% | 677 | $269.83 | |
| 80320 | <1% | 81 | $189.90 | |
| 85379 | <1% | 108 | $149.70 | |
| 86900 | <1% | 274 | $141.45 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 104 | $108.19 |
| 85007 | <1% | 130 | $101.80 | |
| 86901 | <1% | 410 | $96.98 | |
| 87205 | <1% | 149 | $84.58 | |
| 86140 | <1% | 246 | $78.27 | |
| 82607 | <1% | 30 | $55.10 | |
| 82248 | <1% | 302 | $49.65 | |
| 86850 | <1% | 42 | $43.29 | |
| 87807 | <1% | 198 | $29.03 | |
| 83550 | <1% | 14 | $18.28 | |
| 87210 | <1% | 62 | $17.04 | |
| 86885 | <1% | 54 | $14.73 | |
| 83540 | <1% | 14 | $11.72 | |
| 85652 | <1% | 12 | $4.88 | |
| 85651 | <1% | 14 | $2.85 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 162 | $0.00 |
| 82077 | 0% | 162 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODKEY, JOHN (OWNER/VP OF OPERATIONS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.